ENDRA Life Sciences Inc. (NDRA)

Market Cap	5.96M
Revenue (ttm)	n/a
Net Income (ttm)	-9.77M
Shares Out	738.37K
EPS (ttm)	-28.73
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	103,083
Open	8.10
Previous Close	8.07
Day's Range	7.61 - 8.10
52-Week Range	2.90 - 170.63
Beta	-0.18
Analysts	Strong Buy
Price Target	46.00 (+470.01%)
Earnings Date	Aug 13, 2025

About NDRA

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was in...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: May 9, 2017
• Employees: 21
• Stock Exchange: NASDAQ
• Ticker Symbol: NDRA
• Website: https://endrainc.com

Analyst Summary

According to one analyst, the rating for NDRA stock is "Strong Buy" and the 12-month stock price target is $46.0.

Price Target

$46.0

(470.01% upside)

Analyst Consensus: Strong Buy